The Goldman Sachs Group upgraded Immunocore (NASDAQ:IMCR) to "Buy." - Best Stocks

Retrieved on: 2022-12-17 18:52:47

Tags for this article:

Click the tags to see associated articles and topics

The Goldman Sachs Group upgraded Immunocore (NASDAQ:IMCR) to "Buy." - Best Stocks. View article details on hiswai:

Excerpt

In a report that was released on Friday, the equity research analysts at The Goldman Sachs Group upgraded their rating on Immunocore (NASDAQ: ...

Article found on: beststocks.com